Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT

We report a clinical trial testing vaccination of autologous myeloblasts admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells after allogeneic hematopoietic stem cell transplantation (HSCT). Patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) wi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Ho, Vincent T., Kim, Haesook T., Bavli, Natalie, Mihm, Martin, Pozdnyakova, Olga, Piesche, Matthias, Daley, Heather, Reynolds, Carol, Souders, Nicholas C., Cutler, Corey, Koreth, John, Alyea, Edwin P., Antin, Joseph H., Ritz, Jerome, Dranoff, Glenn, Soiffer, Robert J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2017
Teme:
Transplantation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5737123/
https://ncbi.nlm.nih.gov/pubmed/29296875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009084
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki